Utility of PTEN, MLH1, ARID1A, Beta-catenin, Bax and BCL-2 biomarkers in endometrial hyperplasia and endometrioid endometrial carcinoma

被引：0
|
作者：
Dover, D. Kosemetin [1 ]
Senol, S. [1 ]
Aydin, A. [1 ]
机构：
[1] Van Bolge Hastanesi, Patol Lab, Edremit Van, Turkey
来源：
VIRCHOWS ARCHIV | 2015年 / 467卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-09-087
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [1] ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
    Werner, Henrica M. J.
    Berg, Anna
    Wik, Elisabeth
    Birkeland, Even
    Krakstad, Camilla
    Kusonmano, Kanthida
    Petersen, Kjell
    Kalland, Karl H.
    Oyan, Anne M.
    Akslen, Lars A.
    Trovik, Jone
    Salvesen, Helga B.
    MODERN PATHOLOGY, 2013, 26 (03) : 428 - 434
  • [2] ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis
    Asaka, Shiho
    Liu, Ying
    Yu, Zheng-Cheng
    Rahmanto, Yohan Suryo
    Ono, Motoki
    Asaka, Ryoichi
    Miyamoto, Tsutomu
    Yen, Ting -Tai
    Ayhan, Ayse
    Wang, Tian -Li
    Shih, Ie-Ming
    MODERN PATHOLOGY, 2023, 36 (02)
  • [3] ARID1A Regulates Progesterone Receptor Expression in Endometrial Carcinoma and xAtypical Hyperplasia
    Liu, Ying
    Asaka, Shiho
    Wang, Tian-Li
    Shih, Ie-Ming
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 790 - 790
  • [4] Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia
    Orbo, A
    Nilsen, MN
    Arnes, MS
    Pettersen, I
    Larsen, K
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (02) : 141 - 148
  • [5] ARID1A Regulates Progesterone Receptor Expression in Endometrial Carcinoma and xAtypical Hyperplasia
    Liu, Ying
    Asaka, Shiho
    Wang, Tian-Li
    Shih, Ie-Ming
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 790 - 790
  • [6] Diagnostic Importance of PAX2, ARID1A, and FOXA1 Biomarkers in Atypical Endometrial Hyperplasia
    Yildiz, Ozlem Nur
    Topal, Cumhur Selcuk
    Zemheri, Itir Ebru
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (08): : 847 - 851
  • [7] Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study
    Samani, Simin Mirakhor
    Bojnordi, Tahmineh Ezazi
    Zarghampour, Manijeh
    Merat, Sobhan
    Fouladi, Daniel F.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 38 (07) : 999 - 1004
  • [8] CLINICOPATHOLOGICAL FEATURES ASSOCIATED WITH IMMUNOHISTOCHEMISTRY LOSS OF MISMATCH REPAIR PROTEIN MLH1 IN ENDOMETRIOID ENDOMETRIAL CARCINOMA
    de Freitas, D.
    Aguiar, F. N.
    Anton, C.
    Bacchi, C. E.
    Carvalho, J. P.
    Carvalho, F. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A168 - A169
  • [9] Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma
    Pasanen, Annukka
    Loukovaara, Mikko
    Butzow, Ralf
    MODERN PATHOLOGY, 2020, 33 (07) : 1443 - 1452
  • [10] MLH1 and MSH2 immunolabeling in carcinomas: High frequency of MLH1 loss of expression in endometrial carcinoma.
    Smith, KD
    Bronner, MP
    Haggin, RC
    Schmidt, RA
    LABORATORY INVESTIGATION, 1999, 79 (01) : 85A - 85A
12345